Expert Speaker Faculty

Andrew Steinsapir

Director, Gene Therapy Program Lead | Acting Chief Technology Officer

Apertura Gene Therapy

April Sena

Vice President - Technical Operations

Life Edit Therapeutics

Ash Gupta - Viral Vector Process Development & Manufacturing Summit 2025 Speaker

Ashutosh Gupta

Director - Drug Substance Process Development & Manufacturing

Kiniksa Pharmaceuticals International, plc

Hao Liu

Viral Vector Core Senior Research Associate III

UMass Gene Therapy Center

Ishtiaq Khaliq

Gene Therapy & Molecular Biology Sciences Lead

UCB

Jingying Xu

Director of Regulatory Affairs CMC

Kite, a Gilead Company

Jorge Santiago-Ortiz

Sr Director, CMC

Apertura Gene Therapy

Julia Rohlhill

Associate Director, Viral Vector Sciences

Legend Biotech

Kathy Nguyen

Engineer IV

Takeda Pharmaceutical

Kok Seong Lim

Analytical Sciences & Quality Control Expert

Independent Expert

Matthew Weaver

Vice President - Chemistry, Manufacturing & Controls Development

Spirovant Sciences

Michael Datillo

Senior Investigator, Lentiviral Vector Manufacturing Excellence

Johnson & Johnson

Michael DiBiasio - Viral Vector Process Development & Manufacturing Summit 2025 Speaker

Michael DiBiasio-White

Senior Scientist

Ring Therapeutics

Rekha - Viral Vector Process Development & Manufacturing Summit 2025 Speaker

Rekha Iyengar

Senior Scientist Upstream Vector Development

Stanford University

Tony Chikere

Director - Vector Process Development

Sangamo Therapeutics

Valerie Ng

Associate Director, Regulatory CMC

Kite, a Gilead Company

Ying Cai

Executive Director - Manufacturing Sciences & Technology

Ultragenyx Pharmaceutical Inc.

Yuanli Song

Associate Director

Sanofi

SEE FULL AGENDA

PARTNER

February 19-21, 2025
Boston, MA

February 19-21, 2025 | Boston, MA